NEW COAS IN ONCOLOGY GUIDE
QM COAs can help capture slowed decline in physical functioning and well-being. Learn how to illuminate the impact of cancer treatments and therapies using COA measures in a free oncology-focused guide.
Read the GuideAs pharma, biotech, medical device companies and academic researchers race to discover treatments for COVID-19, they require measurement and outcomes reporting for capturing real-world evidence.
__
On COVID-19
COVID-19 has changed the world, and as pharma, biotech, medical device companies and academic researchers race to discover treatments, they require measurement and outcomes reporting that enables them to continue their research and capture real-world evidence.
Pharma sponsors are collaborating with QualityMetric to integrate our patient-reported outcome (PRO) Solutions in COVID-19 studies to understand the significant impact of the infectious disease on functional health status burden. QualityMetric’s PROs are available in over 2,000 linguistically validated translations across electronic, interviewer script and paper mode of administration.
QualityMetric’s SF instruments are also available in daily recall as COVID-19 symptoms can rapidly progress, and custom COVID-SF-12v2 with additional questions focused on fatigue and emotional health.